BUZZ-Insmed Chief Financial Officer Sara Bonstein resigns; stock price drops
路透社2026/10/05 15:06Latest updates as of October 5: - Pharmaceutical company Insmed (INSM.O) shares fell by 8.4%, closing at $101.93. - Sara Bonstein will step down as Chief Financial Officer, effective October 30. - Insmed was mentioned in analyst reports as a potential acquisition target (link). - “One possible reason for today's decline in share price is that the CFO's departure may lead investors to believe an acquisition is less likely in the short term—we note that recent discussions among investors about this possibility have increased,” RBC Capital Markets added. - The company reaffirmed its fiscal 2026 performance guidance and stated it has begun the search for the next CFO. - RBC described the transition as “overall positive,” and noted that since the CFO change will occur after Insmed releases its Q3 results on October 29, the timing should help ensure a smooth transition. - Including intraday fluctuations, the stock has dropped 41.3% year-to-date. (For the convenience of non-English speakers, Reuters automatically translates its reports into several other languages. Since automated translations may be inaccurate or may not include all desired context, Reuters does not guarantee the accuracy of the translated texts, which are provided solely for reader convenience. Reuters is not liable for any damages or losses resulting from the use of this automated translation.)
Latest Developments
October 5 - ** Pharmaceutical company Insmed (INSM.O) shares fell 8.4% to close at $101.93
** Sara Bonstein will step down as Chief Financial Officer, effective October 30
** Insmed is one of the potential acquisition target companies mentioned in analyst reports (link)
** "One possible reason for today's share price decline is that the departure of the CFO may lead investors to believe that an acquisition is less likely in the near term — we note that there has been increased discussion of this possibility among investors recently," RBC Capital Markets added
** The company reaffirmed its fiscal year 2026 guidance and said it has begun the search for its next CFO
** RBC called the transition “overall positive,” and said the timing of the CFO changeover—after Insmed reports third-quarter results on October 29—should promote a smooth handover
** Including intraday fluctuations, the share has fallen a total of 41.3% so far this year
(To facilitate non-English speakers, Reuters has automatically translated its report into several other languages. Due to possible errors in automated translation or incomplete contextual inclusion, Reuters does not guarantee the accuracy of the automated translation, which is provided only for reader convenience. Reuters is not liable for any damage or loss arising from the use of automated translation.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Sector Update: Consumer
01:17 PM EDT, 10/05/2026 (MT Newswires) -- Consumer stocks were higher Monday afternoon, with the State Street Consumer Staples Select Sector SPDR ETF (XLP) and the State Street Consumer Discretionary Select Sector SPDR ETF (XLY) each adding 0.4%. In corporate news, Paramount Skydance (PSKY) Chairman and Chief Executive David Ellison will be chairman and CEO of the combined company following the anticipated close of Paramount's acquisition of Warner Bros. Discovery (WBD), Paramount said. Paramount shares were up 1.6%, and Warner was fractionally higher.
Exchange-Traded Funds Rise, US Equities Higher After Midday
01:10 PM EDT, 10/05/2026 (MT Newswires) -- Broad Market Indicators Broad-market exchange-traded funds IWM and IVV were higher. Actively traded Invesco QQQ Trust (QQQ) added 0.6%. US equity indexes were higher after midday Monday as government bond yields rose and crude oil fell. Energy IShares US Energy ETF (IYE) and the State Street Energy Select Sector SPDR (XLE) were each up about 1.1%. Technology The State Street Technology Select Sector SPDR ETF (XLK) gained 0.4%; iShares US Technology ETF (IYW) added 0.6%, and iShares Expanded Tech Sector ETF (IGM) was 0.6% higher. The State Street SPDR S&P Semiconductor (XSD) slipped 0.6%, and iShares Semiconductor (SOXX) fell 0.2%. Financial The State Street Financial Select Sector SPDR (XLF) added 0.7%. Direxion Daily Financial Bull 3X Shares (FAS) advanced 2.2%, and its bearish counterpart, Direxion Daily Financial Bear 3X Shares (FAZ), declined 1.9%. Commodities Crude oil lost 1.1%, and the United States Oil Fund (USO) fell 1.4%. Natural gas added 0.9%, and the United States Natural Gas Fund (UNG) gained 0.7%. Gold on Comex eased 0.1%, and the State Street SPDR Gold Shares (GLD) lost 0.4%. Silver was up 1.5%, and iShares Silver Trust (SLV) gained 0.7%. Consumer The State Street Consumer Staples Select Sector SPDR (XLP) was 0.5% higher, and the Vanguard Consumer Staples ETF (VDC) rose 0.5%. The State Street Consumer Discretionary Select Sector SPDR (XLY) added 0.4%. VanEck Retail ETF (RTH) was up 0.2%, and the State Street SPDR S&P Retail (XRT) edged up 0.1%. Healthcare The State Street Health Care Select Sector SPDR (XLV) added 0.5%, while iShares US Healthcare (IYH) gained 0.5%, and Vanguard Health Care ETF (VHT) rose 0.6%. IShares Biotechnology ETF (IBB) advanced 0.7%. Industrial The State Street Industrial Select Sector SPDR (XLI) added 0.4%. Vanguard Industrials Index Fund (VIS) rose 0.5%, and iShares US Industrials (IYJ) gained 0.7%. Cryptocurrency In midday activity, bitcoin (BTC-USD) shed 0.2%. Among cryptocurrency ETFs, ProShares Bitcoin ETF (BITO) added 1.2%,
Gold price rises as Europe debt risks boost appeal of haven assets
BUZZ - Musk's comments on TSMC and Terafab cause Intel shares to decline
October 5 — Chip maker Intel (INTC.O) shares fell 2.35% to $116.53. Elon Musk, CEO of Tesla (TSLA.O) and SpaceX (SPCX.O), stated on the X platform Saturday that TSMC and his chip manufacturing project Terafab are in discussions about potential cooperation. On Saturday, Musk responded on the X platform to a screenshot of an article titled “TSMC is exploring a partnership with Elon Musk’s TeraFab project,” writing: “Just at the discussion stage for now, but there could be an outcome.” If TSMC becomes involved, it could challenge Intel’s position in the Terafab project. B Riley Wealth Chief Market Strategist Art Hogan said: “The Musk news appears to be a catalyst, but Intel’s sharp rally in September left the stock susceptible to a pullback.” Tesla and Intel have not yet responded to Reuters’ requests for comment. Driven by strong demand for AI and semiconductor stocks, Intel shares rose roughly 34% in September. Including today’s gains, Intel shares have more than doubled this year. (For the convenience of non-English speakers, Reuters automates the translation of its reports into multiple languages. As automated translations may contain errors or lack needed context, Reuters does not guarantee their accuracy and provides them solely for readers’ convenience. Reuters accepts no liability for damages or losses resulting from the use of automated translation functions.)
Crypto prices
More
